Dr. Mayr is an entrepreneur in residence at Hevolution Foundation and provides consulting services for all aspects of R&D for pharmaceutical products, technologies, and processes. Prior to he was CEO of Vector BioPharmaand has been the Chief Technology Officer for GE Healthcare Life Sciences and was responsible for all R&D investments, research programs, business growth strategy, technology innovation, and R&D talent development across all business areas (BioProcess, Imaging Diagnostics/Contrast Media, Research Tools and Applied Markets, Cell & Gene Therapy, New Opportunities). Previously, he has been working as Vice President & Global Head, Reagents & Assay Development with responsibility for generation of all biological reagents and assay development activities across all therapeutic research areas at AstraZeneca.